Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study - Hirschfield, G M; Gershwin, M E; Strauss, R (Hepatology, 2016)
, et al; PURIFI Study Group.